ACIU - AC Immune S.A. Stock Analysis | Stock Taper

SCREENER COMPARE ANY 2 STOCKS

ACIU

AC IMMUNE S.A.

NASDAQ

$2.65

▼ DOWN 2.21% (-0.06)

KEY STATISTICS

Market Cap$269.70 M

52w High$4.00

52w Low$2.04

Dividend Yield—

Frequency—

P/E-4.91

Volume105.64K

Shares Out.101.77M

COMPANY

LEADERSHIP

Martin Zügel

CHIEF EXECUTIVE

Martin Zügel

ABOUT

SECTOR

Healthcare

WENT PUBLIC

September 23, 2016

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

106

PRICE TARGET

Target High$7.00

Target Low$7.00

Target Median$7.00

Target Consensus$7.00

UPCOMING EARNINGS

DateNov 3, 2026

DayTuesday

Rev. Est.$248.27K

NOV

3

TUE

PRICE

$2.65 ▼ DOWN 2.21% (−$0.06)

About AC Immune S.A.

https://www.acimmune.com ↗

AC Immune SA is a Swiss biotech developing vaccines, antibodies, and small molecules targeting misfolded proteins for neurodegenerative diseases like Alzheimer's, with several candidates in clinical trials and collaborations with major pharma comp...

INDUSTRY

Biotechnology

A PRODUCT AC IMMUNE S.A. IS KNOWN FOR

ACI-24.060

ACI-24.060

ACI-24.060 is an active immunotherapy developed with Takeda to stimulate antibodies against amyloid-beta plaques for Alzheimer's treatment, with key trial results expected in 2026.

COMPETITORS

COMPETITOR

ETFS HOLDING THIS STOCK

ETFS HOLDING

15

LISTED HERE

4

RANKED BY POSITION SIZE

0.01% · 454.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED

100.00%

HOLDERS

64

TOP 12 OF 64 · RANKED BY POSITION SIZE

Metatron Capital Sicav Plc

79.8M sh · $217.8M

19.8M sh · $57.29M

2.6M sh · $10.4M

Wells Fargo & Company/Mn

1.0M sh · $2.92M

Millennium Management LLC

933.3K sh · $2.93M

Renaissance Technologies LLC

840.1K sh · $2M

Blackrock, Inc.

524.3K sh · $1.44M

Acadian Asset Management LLC

464.7K sh · $1.44M

Arrowstreet Capital, Limited Partnership

405.7K sh · $1.12M

Dimensional Fund Advisors LP

390.2K sh · $1.07M

Point72 Asset Management, L.P.

384.8K sh · $1.21M

Northern Trust Corp

282.0K sh · $885.33K

RATINGS SNAPSHOT

Overall rating: C-

Discounted Cash Flow1

Return On Equity1

Return On Assets1

Debt To Equity3

Price To Earnings1

Price To Book2

Overall Score1

INSIDER TRADES

★

DIRECTOR

Buetler Monika

Purchase · 17.8K shares

2026-06-11

★

DIRECTOR

AGUIAR-LUCANDER RENEE

Purchase · 16.6K shares

2026-06-11

★

DIRECTOR

AGUIAR-LUCANDER RENEE

Purchase · 38.9K shares

2026-06-11

★

DIRECTOR, OFFICER: INTERIM CEO

Zuegel Martin

Purchase · 77.8K shares

2026-06-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY

BUY 1

1 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEER	PRICE
DRTS	$14.64	COMPARE
ANRO	$35.13	COMPARE
ANNX	$4.97	COMPARE
CTNM	$17.05	COMPARE
SLN	$13.42	COMPARE
LYEL	$14.53	COMPARE
CLLS	$3.40	COMPARE
AMRN	$13.97	COMPARE